Haishengsu as an adjunct therapy to conventional chemotherapy in patients with non-small cell lung cancer: A pilot randomized and placebo-controlled clinical trial

Complementary Therapies in Medicine

Volumn 17, Issue 1, 2009, Pages 51-55

  Li, Guang Yao ^a   Yu, Xiao Min ^b   Zhang, Hong Wei ^a   Zhang, Bin ^a   Wang, Chun Bo ^b   Xin, Yan Chun ^c   Yang, Chun Zheng ^d   Zhou, Ren Xiang ^b   Wang, Le Xin ^e  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^c Haisheng Oncology Hospital of Qingdao   (China)

^d INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^e CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Chemotherapy; Gastrointestinal reactions; Haishengsu; Non small cell lung cancer

Indexed keywords

CHINESE DRUG; CISPLATIN; HAISHENGSU; MITOMYCIN; PLACEBO; PLANT EXTRACT; TEGILLARCA GRANOSA EXTRACT; UNCLASSIFIED DRUG; VINDESINE;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; MULTIPLE CYCLE TREATMENT; PILOT STUDY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TEGILLARCA GRANOSA;

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; EATING; GASTROINTESTINAL TRACT; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; MOLLUSCA; NAUSEA; PILOT PROJECTS; VOMITING;

EID: 57849125537     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2008.10.002     Document Type: Article

References (17)

1. Jung W.K., Jo H.Y., Qian Z.J., et al. A novel anticoagulant protein with high affinity to blood coagulation factor Va from Tegillarca granosa. J Biochem Mol Biol 40 (2007) 832-838
2. Yao R.Y., Chu X., Zhang Y.J., et al. Anti-tumor effect of Haishengsu extracted from Tegillarca granosa in vitro and in vivo. Chin J Mar Drugs 24 (2005) 33-36
3. Yao R.Y., Zhang H.P., Wang F.H., and Liu W.S. Study of special toxicology of Haishengsu injection. Chin Remedies Clin 4 (2006) 36-40
4. Gkiozos I., Charpidou A., and Syrigos K. Developments in the treatment of non-small cell lung cancer. Anticancer Res 27 (2007) 2823-2837
5. Baggstrom M.Q., Stinchcombe T.E., Fried D.B., Poole C., Hensing T.A., and Socinski M.A. Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis. J Thoracic Oncol 2 (2007) 845-853
6. Nelson K., Walsh D., and Sheehan F. Cancer and chemotherapy-related upper gastrointestinal symptoms: the role of abnormal gastric motor function and its evaluation in cancer patients. Supp Care Cancer 10 (2002) 455-461
7. Morrow G.R., and Roscoe J.A. Hickok: nausea and vomiting. In: Holland J.C. (Ed). Psycho-Oncology. 2nd ed. (1998), Oxford University Press, New York 476-484
8. Schnell F.M. Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. Oncologist 8 (2003) 187-198
9. Schag C.C., Heinrich R.L., and Ganz P.A. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 2 (1984) 187-193
10. Zaniboni A., Barni S., Labianca R., et al., An Italian Group for the study of Digestive Tract Cancer (GISCAD) report. Epirubicin, cisplatin, and continous infusion 5-fluorouracial is an active and safe regiment for patients with advanced gastric cancer. Cancer 76 (1995) 1694-1699
11. Kondo K., Murase M., Kodern Y., et al. Feasibility study in protracted infusion 5 fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer. Oncology 53 (1996) 64-67
12. Non-small cell lung cancer collaborative group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995;311:899-909.
13. Shepherd F.A. Chemotherapy for non-small cell lung cancer: have we reached a new plateau?. Semin Oncol 26 1, Suppl. 4 (1999) 3-11
14. Bonomi P. Eastern Cooperative Oncology Group experience with chemotherapy in advanced non-small-cell lung cancer. Chest 111 Suppl. 1 (1998) 13S-16S
15. Spain R.C. The case for mitomycin in non-small cell lung cancer. Oncology 50 Suppl. 1 (1993) 35-50
16. Liu Z.X., Zhan S.M., Yao R.Y., et al. Anti-tumor effect of Haishengsu injection. Chin J Mar Drugs 23 (2004) 35-37
17. Wang Z.L., Chu X., Yang X., et al. Anti-tumor effect of extraction from Tegillarca granosa. Shandong Med J 46 (2006) 15-17